A trial led by the Duke Clinical Research Institute, Durham, has investigated the long-term safety and efficacy of supplementing heart failure patients with iron. In a paper, "Ferric Carboxymaltose in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results